Syqe

Tel Aviv, Israel Founded: 2011 • Age: 15 yrs Acquired By Vectura
Precise dosing inhaler for medical cannabis is developed.
Annual revenue - Latest available
Total funding $75.7M 4 rounds
Employees - Tracked headcount
Investors 5 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Syqe

Syqe is a company based in Tel Aviv (Israel) founded in 2011 by Perry Davidson and Benny Shwartz was acquired by Vectura in July 2023. Syqe has raised $75.67 million across 4 funding rounds from investors including OurCrowd, Philip Morris International and Phillips Medisize. Syqe offers products and services including SyqeAir Inhaler, SyqeAir Cartridge, and Case for SyqeAir Inhaler. Syqe operates in a competitive market with competitors including Kanabo, Dosist, Philter, Resolve Digital Health and Fernway, among others.

  • Headquarter Tel Aviv, Israel
  • Founders Perry Davidson, Benny Shwartz
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Syqe
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $75.67 M (USD)

    in 4 rounds

  • Latest Funding Round
    $50 M (USD), Series A

    Dec 31, 2018

  • Investors
    OurCrowd

    & 4 more

  • Employee Count
    Not available
  • Acquired by
    Vectura

    (Jul 18, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Syqe

Syqe offers a comprehensive portfolio of products and services, including SyqeAir Inhaler, SyqeAir Cartridge, and Case for SyqeAir Inhaler.

Product name locked
Category locked
Primary

Device for precise metered-dose cannabis administration

Product name locked
Category locked
Locked

Cartridges providing cannabis doses for the inhaler

Product name locked
Category locked
Locked

Protective case to store and carry the inhaler

Funding Insights of Syqe

Syqe has successfully raised a total of $75.67M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $50 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Syqe

Syqe has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include OurCrowd, Philip Morris International and Phillips Medisize.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity investments in Israel are managed by Shavit Capital.
Locked Locked Locked
Multi-category tobacco products, including cigarettes and heated options, are manufactured.
Locked Locked Locked
Martin Bauer is engaged in producing plant-based products for various industries.
Locked Locked Locked
Premium access

Investor details for Syqe

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Syqe

Investments
Premium access

Investment portfolio details for Syqe

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Syqe

Premium access

Detailed financials for Syqe

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Syqe Comparisons

Syqe Primary company
Description
Precise dosing inhaler for medical cannabis is developed.
Location
Tel Aviv, Israel
Founded Year
2011
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Syqe

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Syqe

Syqe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kanabo, Dosist, Philter, Resolve Digital Health and Fernway, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Cannabis-based medical and consumer products are developed by Kanabo.
Locked Locked Locked
Cannabis strains are sourced and processed for therapeutic products.
Locked Locked Locked
Vapour cigarettes are branded and offered by Philter.
Locked Locked Locked
Smart inhalers and health monitoring devices are developed for wellness.
Locked Locked Locked
Cannabis-based vaporizer cartridges with natural terpenes are provided.
Premium access

Detailed competitors of Syqe

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Syqe

Premium access

Complete news archive for Syqe

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syqe

Syqe was founded in 2011 and raised its 1st funding round 4 years after it was founded.

Syqe is headquartered in Tel Aviv, Israel.

Hagit Kamin is the current CEO of Syqe.

Syqe is a funded company, having raised a total of $75.67M across 4 funding rounds to date.

Syqe was established in 2011 in Tel Aviv, Israel, within the medical cannabis sector. An inhalation device called Air is produced to deliver controlled THC doses. Pain reduction is facilitated, psychoactive effects are managed, and daily functioning is supported through this system. Operations center on device development and precise medication administration for therapeutic use.

Syqe's top competitors include Fernway, Dosist and Kanabo.

Syqe offers SyqeAir Inhaler, SyqeAir Cartridge, and Case for SyqeAir Inhaler.

Syqe has 5 investors. Key investors include OurCrowd, Philip Morris International, Phillips Medisize, Shavit Capital, and Martin Bauer.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available